膝前大隐静脉第三部分:文献系统评价与支付方覆盖政策——获美国静脉与淋巴学会、美国静脉论坛及国际静脉学联盟认可
本研究通过PRISMA框架系统评价膝前大隐静脉反流治疗的文献,并横断面分析保险政策。226项保险政策中,155项(68.6%)允许膝前大隐静脉消融覆盖,62项(27.4%)未明确覆盖,9项(4.0%)明确不覆盖;155项提供覆盖的政策中98项(62.2%)设有条件。作者认为静脉治疗专家应继续倡导保险机构更新政策。
要点
- 226项保险政策中155项(68.6%)允许膝前大隐静脉消融覆盖
- 62项(27.4%)未明确覆盖,9项(4.0%)明确不覆盖
- 155项提供覆盖的政策中98项(62.2%)设有条件如要求先治疗大隐静脉
核心结论
- 静脉治疗专家应继续倡导保险机构更新其静脉曲张治疗政策,以反映大量临床证据,使膝前大隐静脉反流患者得到适当治疗。
研究设计与样本
- 采用PRISMA框架进行文献检索的系统评价,并对膝前大隐静脉治疗的保险政策进行横断面分析。
主要发现
- 共审查226项保险政策,其中155项(68.6%)允许膝前大隐静脉消融覆盖。
- 62/226项(27.4%)保险政策未明确膝前大隐静脉治疗覆盖,9/226项(4.0%)明确不覆盖。
- 155项提供膝前大隐静脉覆盖的政策中,98项(62.2%)设有条件,如要求先治疗大隐静脉。
关键数值与推荐
- 155/226项(68.6%)保险政策允许膝前大隐静脉消融覆盖。
- 62/226项(27.4%)保险政策未明确膝前大隐静脉治疗覆盖。
- 9/226项(4.0%)保险政策明确膝前大隐静脉治疗不覆盖。
- 155项提供覆盖的政策中98项(62.2%)设有条件如要求先治疗大隐静脉。
临床怎么用
- 作者认为静脉治疗专家应继续倡导保险机构更新静脉曲张治疗政策以反映临床证据。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study is to systemically review the literature on Anterior Saphenous Vein (ASV) reflux treatment and insurance impediments to treatment coverage. METHODS: A literature search was performed using a PRISMA framework. In addition, a cross-sectional analysis of insurance policies for ASV treatment was evaluated. RESULTS: Published evidence and treatment considerations in the literature for ASV treatment are discussed. In 155 of 226 (68.6%) insurance policies reviewed coverage of ASV ablation was allowed while 62/226 (27.4%) did not specify coverage and 9/226 (4.0%) specified ASV treatment was not covered. Of the 155 that provide ASV coverage, 98 (62.2%) provide coverage with criteria such as requiring prior treatment of the great saphenous vein. CONCLUSIONS: Vein treatment experts should continue to advocate to insurance carriers to update their varicose vein treatment policies to reflect the substantial clinical evidence so that patients with ASV reflux can be appropriately treated.
引用
- Drgastin R, Boyle EM, Labropoulos N, et al. The anterior saphenous vein. Part 3. Systematic review of the literature and payor coverage policies. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38551528. doi:10.1016/j.jvsv.2024.101856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。